# Targeted Therapy to Increase RAI Uptake in Metastatic DTC

> **NCT05024929** · — · RECRUITING · sponsor: **Children's Hospital of Philadelphia** · enrollment: 32 (estimated)

## Conditions studied

- Papillary Thyroid Cancer
- Pediatric Cancer
- Differentiated Thyroid Cancer

## Interventions

- **PROCEDURE:** Whole body scan

## Key facts

- **NCT ID:** NCT05024929
- **Lead sponsor:** Children's Hospital of Philadelphia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-07-16
- **Primary completion:** 2031-02-01
- **Final completion:** 2033-02-01
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2025-11-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05024929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05024929, "Targeted Therapy to Increase RAI Uptake in Metastatic DTC". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT05024929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
